U.S. Stem Cell, Inc.
USRM
$0.0001
$0.000.00%
| Weiss Ratings | USRM - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Unrated | |||
| Risk Index | Unrated | |||
| Risk Grade | U | |||
| Reward Grade | U | |||
| Rating Factors | USRM - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | Unrated | |||
| Growth Index | Unrated | |||
| Efficiency Index | Unrated | |||
| Solvency Index | Unrated | |||
| Total Return Index | Unrated | |||
| Volatility Index | Unrated | |||
| Beta / Standard Deviation | USRM - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 102.65 | |||
| Price History | USRM - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 0.00% | |||
| 30-Day Total Return | -- | |||
| 60-Day Total Return | -- | |||
| 90-Day Total Return | 0.00% | |||
| Year to Date Total Return | 0.00% | |||
| 1-Year Total Return | -- | |||
| 2-Year Total Return | -97.06% | |||
| 3-Year Total Return | -98.61% | |||
| 5-Year Total Return | -98.25% | |||
| 52-Week High % Change | -50.00% | |||
| 52-Week Low % Change | 9,900.00% | |||
| Price | USRM - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $0.00 | |||
| 52-Week Low Price | $0.00 | |||
| 52-Week Low Price (Date) | Apr 10, 2024 | |||
| 52-Week High Price (Date) | Mar 04, 2025 | |||
| Valuation | USRM - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 66.15K | |||
| Enterprise Value | -- | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -0.01 | |||
| Earnings Per Share Growth | -30.56% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 1.00 | |||
| Price/Book (Q) | 0.00 | |||
| Enterprise Value/Revenue (TTM) | -- | |||
| Price | $0.00 | |||
| Enterprise Value/EBITDA (TTM) | -- | |||
| Enterprise Value/EBIT | -- | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | USRM - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 634.85M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | USRM - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 954 835 1500 | |||
| Address | 1560 Sawgrass Corporate Parkway Sunrise, FL 33323 | |||
| Website | www.us-stemcell.com | |||
| Country | United States | |||
| Year Founded | 1999 | |||
| Profitability | USRM - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -2,098.04% | |||
| Profit Margin | -3,485.24% | |||
| Management Effectiveness | USRM - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -1,807.14% | |||
| Return on Equity | -- | |||
| Income Statement | USRM - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 82.00K | |||
| Total Revenue (TTM) | 82.00K | |||
| Revenue Per Share | $0.00 | |||
| Gross Profit (TTM) | 58.40K | |||
| EBITDA (TTM) | -- | |||
| EBIT (TTM) | -1.72M | |||
| Net Income (TTM) | -2.86M | |||
| Net Income Avl. to Common (TTM) | -2.86M | |||
| Total Revenue Growth (Q YOY) | -15.25% | |||
| Earnings Growth (Q YOY) | 11.61% | |||
| EPS Diluted (TTM) | -0.01 | |||
| EPS Diluted Growth (Q YOY) | 30.77% | |||
| Balance Sheet | USRM - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 5.10K | |||
| Cash Per Share (Q) | $0.00 | |||
| Total Current Assets (Q) | 68.00K | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | -14.75M | |||
| Current Ratio (Q) | 0.005 | |||
| Book Value Per Share (Q) | -$0.02 | |||
| Total Assets (Q) | 68.00K | |||
| Total Current Liabilities (Q) | 14.08M | |||
| Total Debt (Q) | 10.08M | |||
| Total Liabilities (Q) | 14.81M | |||
| Total Common Equity (Q) | -14.75M | |||
| Cash Flow | USRM - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -- | |||
| Cash from Financing (TTM) | 270.60K | |||
| Net Change in Cash (TTM) | -34.20K | |||
| Levered Free Cash Flow (TTM) | -479.00K | |||
| Cash from Operations (TTM) | -304.90K | |||
